Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameMedsci
Stock Code02415
Company Full NameTo be extracted
Industry軟件服務
Principal Activities公司于中國運營在線專業醫師平臺。
Listing Date2023-04-27
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市松江區莘磚公路258號34號樓18樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://ir.medsci.cn/zh_cn/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 9.10 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone Share51.6%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 60,778,900

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway None
HK Market Cap ---
Est. Threshold ---
Analysis Result 无法确定入通路径

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 9.2
First Day OpenHK$ 8.85
First Day Change1.10%
First Day Volume6280550.0
First Day Turnover56732200.0
Use of Proceeds
1、約45%所得款項凈額,或約242.19百萬港元預計將用于業務擴張。 2、約35%所得款項凈額,或約188.37百萬港元預計將用于進一步的技術開發。 3、約15%所得款項凈額,或約80.73百萬港元預計將用于我們的潛在投資及收購或與能夠與我們業務產生協同效應的公司建立戰略聯盟。 4、約5%所得款項凈額,或約26.91百萬港元預期將用作營運資金及一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 MACQUARIE CAPITAL LIMITED CE AAC534
Overall Coordinators (2)
中国国际金融香港证券有限公司 CE AEN894 MACQUARIE CAPITAL LIMITED CE AAC534
Joint Bookrunners (11)
中国国际金融香港证券有限公司 CE AEN894 MACQUARIE CAPITAL LIMITED CE AAC534 建银国际金融有限公司 CE AJO225 海通国际证券有限公司 CE AAF806 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 Dragonstone Capital Management Limited CE BGM303 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 FIRST SHANGHAI SECURITIES LIMITED CE ABV488 China Sunrise Securities (International) Limited CE AFS030 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855 富途证券国际(香港)有限公司 CE AZT137
Joint Lead Managers (14)
中国国际金融香港证券有限公司 CE AEN894 MACQUARIE CAPITAL LIMITED CE AAC534 建银国际金融有限公司 CE AJO225 海通国际证券有限公司 CE AAF806 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 Dragonstone Capital Management Limited CE BGM303 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 FIRST SHANGHAI SECURITIES LIMITED CE ABV488 China Sunrise Securities (International) Limited CE AFS030 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855 富途证券国际(香港)有限公司 CE AZT137 uSmart Securities Limited CE BJA907 SILVERBRICKS SECURITIES COMPANY LIMITED CE BLN458 Livermore Holdings Limited CE BJN764

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Harvest International Premium Value (Secondary Market) Fund SPC 109,898,425 HKD — 18.08% — 6 months 2023-10-27
2 安吉国融创业投资有限公司 23,548,525 HKD — 3.87% — 6 months 2023-10-27
3 安吉国融建设有限公司 47,099,325 HKD — 7.75% — 6 months 2023-10-27
4 安吉交投实业发展有限公司 23,548,525 HKD — 3.87% — 6 months 2023-10-27
5 安吉七彩灵峰乡村旅游投资有限公司 15,699,775 HKD — 2.58% — 6 months 2023-10-27
6 广发全球资本有限公司 94,198,650 HKD — 15.50% — 6 months 2023-10-27

Directors & Management

PositionChinese nameEnglish Name
Chairman張發寶—
Company Secretary楊春,關秀姸—
No director data available.

Major Shareholders

Major Shareholders & HoldingsMicrohealth Limited(29.30%);Dtx Health Limited(23.32%);Dragon Step Ventures Limited(8.87%);Meiyue Limited(6.89%);意像架構投資(香港)有限公司(6.21%)
About this page

This page shows Medsci (02415) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect